These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34313009)

  • 1. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
    Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D
    Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
    Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
    Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
    Wang YL; Zhang YY
    Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma.
    Wang X; Gao Y; Miao R; Li L; Nanding A; Liu Y; Zhang X
    Am J Cancer Res; 2023; 13(11):5236-5253. PubMed ID: 38058815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and Validating an Angiogenesis-related Signature for the Prognosis of Head and Neck Squamous Cell Carcinoma.
    Hou Y; Pang H; Xu X; Zhao D
    Curr Med Chem; 2024 May; ():. PubMed ID: 38752633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature.
    Cao X; Ge Y; Yan Z; Hu X; Peng F; Zhang Y; He X; Zong D
    J Radiat Res; 2024 Jan; 65(1):10-27. PubMed ID: 37981296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma.
    Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H
    Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel hypoxia-associated gene signature for prognosis prediction in head and neck squamous cell carcinoma.
    Luo J; Huang Y; Wu J; Dai L; Dong M; Cheng B
    BMC Oral Health; 2023 Nov; 23(1):864. PubMed ID: 37964257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
    Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
    EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel gene-based model for prognosis prediction of head and neck squamous cell carcinoma.
    Li Y; Li P; Liu Y; Geng W
    Heliyon; 2024 Apr; 10(8):e29449. PubMed ID: 38660262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel necroptosis-related model predicts the prognosis and immunocompetence of head and neck squamous cell carcinoma.
    Zhang J; Wang A; Qiu L
    Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):219-226. PubMed ID: 38015517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
    Wu ZH; Yun-Tang ; Cheng Q
    Cell Transplant; 2020; 29():963689720929308. PubMed ID: 32452220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma.
    Lu Y; Mai Z; Zheng J; Lin P; Lin Y; Cui L; Zhao X
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer.
    Wei X; Hu W; Mao K
    Medicine (Baltimore); 2023 Feb; 102(5):e32766. PubMed ID: 36749233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma.
    Liu H; Ye Z; Wang X; Wu Y; Deng C
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101937. PubMed ID: 38844022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling to predict overall survival risk in gastric cancer: development and validation of a nomogram to optimize clinical management.
    Ma X; Chen H; Wang G; Li L; Tao K
    J Cancer; 2020; 11(15):4352-4365. PubMed ID: 32489454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma.
    Lee MK; Woo SR; Noh JK; Min S; Kong M; Lee YC; Ko SG; Eun YG
    Mol Cancer Ther; 2024 Sep; 23(9):1348-1359. PubMed ID: 38959066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel methylated DNA marker ZNF569 for head and neck squamous cell carcinoma.
    Liu X; Zhao X; Gou C
    J Cancer; 2019; 10(10):2250-2260. PubMed ID: 31258729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer.
    Burkitt K
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.